Background: The use of a length/weight-based tape (LBT) for equipment size and drug dosing for pediatric patients is recommended in a joint statement by multiple national organizations. A new system, known as Handtevy™, allows for rapid determination of critical drug doses without performing calculations. Objective: To compare two LBT systems for dosing errors and time to medication administration in simulated prehospital scenarios. Methods: This was a prospective randomized trial comparing the Broselow Pediatric Emergency Tape™ (Broselow) and Handtevy LBT™ (Handtevy). Paramedics performed 2 pediatric simulations: cardiac arrest with epinephrine administration and hypoglycemia mandating dextrose. Each scenario was repeated utilizing both systems with a 1 year-old and 5 year-old size manikin. Facilitators recorded identified errors and time points of critical actions including time to medication. Results: We enrolled 80 paramedics, performing 320 simulations. For Dextrose, there were significantly more errors with Broselow (63.8 %) compared to Handtevy (13.8%) and time to administration was longer with the Broselow system (220 seconds vs. 173 seconds). For epinephrine, the LBTs were similar in overall error rate (Broselow 21.3% vs. Handtevy 16.3%) and time to administration (89 vs. 91 seconds). Cognitive errors were more frequent when using the Broselow compared to Handtevy, particularly with dextrose administration. The frequency of procedural errors was similar between the two LBT systems. Conclusion: In simulated prehospital scenarios, use of the Handtevy LBT system resulted in fewer errors for dextrose administration compared to the Broselow LBT, with similar time to administration and accuracy of epinephrine administration.
Purpose: Asthma is a chronic inflammatory disorder of airways resulting in recurrent exacerbations of wheezing, breathlessness, chest tightness, excessive mucus production, and cough. We hypothesize that intravenous magnesium sulfate (IV MgSO 4 ) is an effective adjunctive therapy in the treatment of acute severe asthma. We propose that IV MgSO 4 at 75mg/kg improves the Clinical Asthma Severity Score (CASS) by 2 points at 3 hours in patients (pts) with acute severe asthma. Methods: Prospective, randomized, double-blind, placebo-controlled pilot study using a convenience sample presenting to an urban children's emergency department with an acute asthma exacerbation. Pts with a CASS Q 8 following 3 Albuterol/Ipatropium bromide nebs, a 1 hour 20mg Albuterol neb, and 2mg/kg of steroids were enrolled. Pts received either 75mg/kg (max 3 grams) IV MgSO 4 or saline infusion over 30 min. Baseline and serial assessments of CASS, PEFR, vital signs, O2 sat., and physical exam were performed every 20 min. for a total of 120 min. Results: 90 pts were enrolled, 74 had at least one measurement beyond baseline. Median age was 6.2 yrs (range 1.9 Y 15.5 yrs), 55.3% male, mean CASS at baseline (6 0 )= 10.7 T 2.3. Using a mixed model ANCOVA controlling for baseline covariates, the effect of time for both groups was F (6,74) = 13.71, P G 0.0001. The effect of treatment group was F (1,74) = 0.02, P = 0.89. Mean for placebo at time 0 (6 plac0 ) = 10.39 (T0.37) versus treatment mean at time 0 (6 mg0 ) = 10.95 (T0.37); 6 plac40 = 9.19 (T0.42) vs 6 mg40 = 9.14 (T0.42); 6 plac80 = 8.49 (T0.42) vs 6 mg80 = 8.39 (T0.42); 6 plac120 = 8.08 (T0.45) vs 6 mg120 = 8.12 (T0.49). 15 pts required NS bolus during med infusion, 3 pts required BIPAP, and 1 pt required intubation. Conclusion: Intravenous magnesium sulfate is not a useful adjunctive therapy in the treatment of acute severe asthma exacerbations in children.Purpose: Asthma is one of the leading causes of childhood emergency department (ED) utilization despite medical advances in the field. This study examined predictors of ED utilization for asthma that could help decrease ED utilization. Methods: Project S.T.A.R. (Support for Treatment of Asthma Research) is a 4-year prospective cohort study of 172 low-income, urban, predominantly African American children with persistent asthma. Participants were 6Y12 yrs old with controller medication prescriptions from their primary care physicians.Patients and their primary caregivers were assessed twice, at baseline and follow-up (mean = 60 wks, range = 52Y130 wks) for medication adherence, asthma symptoms, asthma knowledge, and certain psychosocial variables. Medication adherence was measured prospectively with electronic monitoring devices over a 14 day period. Medical records were reviewed for asthma related ED visits, hospitalizations, and primary care visits. Results: Analyses were conducted on 165 participants who had complete medical records and adherence data. The median age was 9 yrs, 62% were male; 34.5% of participants had one or more ED vis...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.